Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin and methylprednisolone for in-hospital cardiac arrest
2017-004773-13Phase 2Completed
- Sponsor
- Research Center for Emergency Medicine, Aarhus University
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cardiac arrest (SCA) comparing Vasopressin + methylprednisolone with Placebo (2 arms). Primary endpoint: Return of spontaneous circulation. Started Jan 2018; status: completed.
02
Drugs
vasopressinmethylprednisolone
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2017-004773-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004773-13.